R-Bridge Healthcare Investment Advisory’s $60 million non-recourse loan agreement with Paratek Pharmaceuticals

Goodwin Procter LLP advised R-Bridge Healthcare Investment Advisory on the deal. R-Bridge Healthcare Investment Advisory, Ltd. announced its $60 million non-recourse loan agreement with Paratek Pharmaceuticals,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here